Two-thirds of patients admitted to the Intensive Care Unit after a cardiac arrest die in the context of treatment withdrawal after a multimodal evaluation that determines an unfavorable neurological outcome. This study will evaluate the Pupillary Pain Index (PPI) in the neurological prognosis after cardiac arrest. The PPI is determined by recording of pupillary dilatation with a videopupillometer after a calibrated and incremented nociceptive stimulus on a cutaneous metamere.
Cardiorespiratory arrest is associated with high mortality and morbidity rates. The direct consequence of a cardio-circulatory arrest is the absence of blood flow allowing oxygenation of the organs and consequently formation of ischemic lesions. Anoxic cerebral lesions are common in the aftermath of a cardiac arrest and often lead to the death of patients when active therapies are stopped after a multimodal prognostication that indicates that a poor outcome is very likely. It is of paramount importance to optimize the sensitivity of the prognostication strategy in detecting good neurological outcome. A multimodal approach to the prognostic assessment is essential, and must include at least clinical examination, electrophysiology exploration (electroencephalography and/or evoked potentials) and biomarker analysis. Although the most reliable predictors did not give false positives in most studies, none of them, considered individually, can establish an unfavorable prognosis with an absolute degree of certitude. For these reasons it is interesting to evaluate new prognostication tools. The videopupillometry allows precise, reproducible and repeated measurement of changes in pupil diameter in response to a painful or a luminous stimulus. Pupillary pain reflex analysis is usually used to assess the degree of analgesia in a non-communicative patient during general anesthesia and neuromuscular blockade. The PPI score is determined at the bedside by recording pupillary dilatation after a calibrated and incremented nociceptive stimulus (electrical current between 5 and 60mA) applied to a skin metamere with two electrodes. Automated pupillometry measurement has been recently developed to help support prognostication, with a quantitative pupillary light reflex measurement. The aim of this study is to evaluate the Pupillary Pain Index in the neurological prognosis after a cardiac arrest by correlating the PPI at 48h from the patient's arrival to the CPC score at 3 months.
Study Type
OBSERVATIONAL
Enrollment
60
Measurement of PPI with a pupillometer
Score Cerebral Performance Category (CPC)
Good outcome defined as CPC 1-2, poor outcome defined as CPC 3-5
Time frame: 3 months
Characteristics of electroencephalography pattern
Classification of Synek, type of pattern (Very malignant, malignant or benign)
Time frame: Day 2, day 3, day 5, day 7
Biomarkers
Value of seric Neuron Specific Enolase
Time frame: 24 hours, 48 hours
Glasgow motor score
Motor response component of the Glasgow Coma Scale, ranging from 1 (no response) to 6 (normal response)
Time frame: 24 hours, 48 hours, day 5, day 7
ICU parameters
Ventilator days, Length of stay
Time frame: Day 14
Evoked Potentials
Presence or absence of the N20 component of the evoked potentials
Time frame: Day 14
Neurological pupil index
standardized evaluation of pupil reactivity ranging from 0 (sluggish or abnormal pupils) to 5 (normally reactive pupils)
Time frame: Day 2, day 3
Diameter of the pupil
In millimeters (pupillometry measure)
Time frame: 24 hours, 48 hours, 72 hours
Percentage of pupil dilatation
Pupillometry measure
Time frame: 24 hours, 48 hours, 72 hours
Latency of pupil dilatation
In milliseconds (pupillometry measure)
Time frame: 24 hours, 48 hours, 72 hours
Velocity of pupil dilatation
In millimeters per second (pupillometry measure)
Time frame: 24 hours, 48 hours, 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.